Clinical Trials
2 trialsNCT04197687 2023-12-18
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery
Academic and Community Cancer Research United
Phase 2 Unknown
NCT05036005 2023-04-18
NeoON
Institut fuer Frauengesundheit
Phase 4 Unknown